Sign In   |   Register
EAS Advanced Course on Precision Medicine in Atherosclerosis, Paris - Scientific Programme
Share |
Thursday, October 05, 2017 
 18:30-19:00  Arrival and registration at the restaurant   
 19:00-22:00  Networking dinner  
Friday, October 06, 2017 
Session 1: Morning Novel Diagnostics towards improved patient
stratification and targeted therapy
08:30 Welcome: Introduction and Objectives Eric Bruckert
08:40 Precision Cardiovascular Medicine: an unmet need or just a fashion? Eran Leitersdorf
09:10 Human Genetics from validation of novel cardiovascular drug targets to molecular diagnosis Alain Carrié
09:40 Do Novel Biomarkers improve cardiovascular risk stratification? Arnold Von Eckardstein
10:10  Q & A   
10:30 Break
11:00 Is there a role for Advanced Atherosclerosis Imaging in targeted cardiovascular therapy? Erik Stroes
11:30 Nutrigenomics for prevention and treatment of obesity Judith Aron-Wisnewsky
12:00 How is the Pharmaceutical Industry preparing for the new era of Precision Cardiovascular Medicine? Carolina Häfliger
12:30  Q & A   
12:50 Lunch break  
Session 2: Afternoon Therapeutic considerations based on the
genetic background and disease phenotypes
13:50 Identification of novel targets in Hypertension and priorities for drug development David Rosenbaum
14:20 Can we refine strategy on HDL by new pharmacological approaches? John Chapman
14:50 Will precision medicine help tailor dyslipidemia treatment? Alberto Zambon
15:20 Panel Discussion - All speakers  led by Eric Bruckert
16:20 Concluding Remarks Eric Bruckert
16:30 Departures
Membership Software Powered by YourMembership  ::  Legal